Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cancer Biopsy Instruments and Kits Market Growth 2022-2028

  • LP 4877718
  • 105 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cancer Biopsy Instruments and Kits will have significant change from previous year. According to our (LP Information) latest study, the global Cancer Biopsy Instruments and Kits market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cancer Biopsy Instruments and Kits market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cancer Biopsy Instruments and Kits market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cancer Biopsy Instruments and Kits market, reaching US$ million by the year 2028. As for the Europe Cancer Biopsy Instruments and Kits landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Cancer Biopsy Instruments and Kits players cover QIAGEN NV, Illumina, Inc., Becton, Dickinson and Company, and Myriad Genetics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Biopsy Instruments and Kits market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Cancer Biopsy Instruments

Cancer Biopsy Kits

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Breast Cancer

Colorectal Cancer

Cervical Cancer

Lung Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

QIAGEN NV

Illumina, Inc.

Becton, Dickinson and Company

Myriad Genetics

Thermo Fisher Scientific, Inc.

BIOCEPT, INC.

ANGLE plc

Hologic, Inc.

Lucence Diagnostics Pte. Ltd.

Danaher Corporation

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Biopsy Instruments and Kits Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cancer Biopsy Instruments and Kits by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cancer Biopsy Instruments and Kits by Country/Region, 2017, 2022 & 2028

2.2 Cancer Biopsy Instruments and Kits Segment by Type

2.2.1 Cancer Biopsy Instruments

2.2.2 Cancer Biopsy Kits

2.3 Cancer Biopsy Instruments and Kits Sales by Type

2.3.1 Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2017-2022)

2.3.2 Global Cancer Biopsy Instruments and Kits Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cancer Biopsy Instruments and Kits Sale Price by Type (2017-2022)

2.4 Cancer Biopsy Instruments and Kits Segment by Application

2.4.1 Breast Cancer

2.4.2 Colorectal Cancer

2.4.3 Cervical Cancer

2.4.4 Lung Cancer

2.4.5 Others

2.5 Cancer Biopsy Instruments and Kits Sales by Application

2.5.1 Global Cancer Biopsy Instruments and Kits Sale Market Share by Application (2017-2022)

2.5.2 Global Cancer Biopsy Instruments and Kits Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cancer Biopsy Instruments and Kits Sale Price by Application (2017-2022)

3 Global Cancer Biopsy Instruments and Kits by Company

3.1 Global Cancer Biopsy Instruments and Kits Breakdown Data by Company

3.1.1 Global Cancer Biopsy Instruments and Kits Annual Sales by Company (2020-2022)

3.1.2 Global Cancer Biopsy Instruments and Kits Sales Market Share by Company (2020-2022)

3.2 Global Cancer Biopsy Instruments and Kits Annual Revenue by Company (2020-2022)

3.2.1 Global Cancer Biopsy Instruments and Kits Revenue by Company (2020-2022)

3.2.2 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Company (2020-2022)

3.3 Global Cancer Biopsy Instruments and Kits Sale Price by Company

3.4 Key Manufacturers Cancer Biopsy Instruments and Kits Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cancer Biopsy Instruments and Kits Product Location Distribution

3.4.2 Players Cancer Biopsy Instruments and Kits Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cancer Biopsy Instruments and Kits by Geographic Region

4.1 World Historic Cancer Biopsy Instruments and Kits Market Size by Geographic Region (2017-2022)

4.1.1 Global Cancer Biopsy Instruments and Kits Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cancer Biopsy Instruments and Kits Annual Revenue by Geographic Region

4.2 World Historic Cancer Biopsy Instruments and Kits Market Size by Country/Region (2017-2022)

4.2.1 Global Cancer Biopsy Instruments and Kits Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cancer Biopsy Instruments and Kits Annual Revenue by Country/Region

4.3 Americas Cancer Biopsy Instruments and Kits Sales Growth

4.4 APAC Cancer Biopsy Instruments and Kits Sales Growth

4.5 Europe Cancer Biopsy Instruments and Kits Sales Growth

4.6 Middle East & Africa Cancer Biopsy Instruments and Kits Sales Growth

5 Americas

5.1 Americas Cancer Biopsy Instruments and Kits Sales by Country

5.1.1 Americas Cancer Biopsy Instruments and Kits Sales by Country (2017-2022)

5.1.2 Americas Cancer Biopsy Instruments and Kits Revenue by Country (2017-2022)

5.2 Americas Cancer Biopsy Instruments and Kits Sales by Type

5.3 Americas Cancer Biopsy Instruments and Kits Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cancer Biopsy Instruments and Kits Sales by Region

6.1.1 APAC Cancer Biopsy Instruments and Kits Sales by Region (2017-2022)

6.1.2 APAC Cancer Biopsy Instruments and Kits Revenue by Region (2017-2022)

6.2 APAC Cancer Biopsy Instruments and Kits Sales by Type

6.3 APAC Cancer Biopsy Instruments and Kits Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cancer Biopsy Instruments and Kits by Country

7.1.1 Europe Cancer Biopsy Instruments and Kits Sales by Country (2017-2022)

7.1.2 Europe Cancer Biopsy Instruments and Kits Revenue by Country (2017-2022)

7.2 Europe Cancer Biopsy Instruments and Kits Sales by Type

7.3 Europe Cancer Biopsy Instruments and Kits Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cancer Biopsy Instruments and Kits by Country

8.1.1 Middle East & Africa Cancer Biopsy Instruments and Kits Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cancer Biopsy Instruments and Kits Revenue by Country (2017-2022)

8.2 Middle East & Africa Cancer Biopsy Instruments and Kits Sales by Type

8.3 Middle East & Africa Cancer Biopsy Instruments and Kits Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cancer Biopsy Instruments and Kits

10.3 Manufacturing Process Analysis of Cancer Biopsy Instruments and Kits

10.4 Industry Chain Structure of Cancer Biopsy Instruments and Kits

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cancer Biopsy Instruments and Kits Distributors

11.3 Cancer Biopsy Instruments and Kits Customer

12 World Forecast Review for Cancer Biopsy Instruments and Kits by Geographic Region

12.1 Global Cancer Biopsy Instruments and Kits Market Size Forecast by Region

12.1.1 Global Cancer Biopsy Instruments and Kits Forecast by Region (2023-2028)

12.1.2 Global Cancer Biopsy Instruments and Kits Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cancer Biopsy Instruments and Kits Forecast by Type

12.7 Global Cancer Biopsy Instruments and Kits Forecast by Application

13 Key Players Analysis

13.1 QIAGEN NV

13.1.1 QIAGEN NV Company Information

13.1.2 QIAGEN NV Cancer Biopsy Instruments and Kits Product Offered

13.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 QIAGEN NV Main Business Overview

13.1.5 QIAGEN NV Latest Developments

13.2 Illumina, Inc.

13.2.1 Illumina, Inc. Company Information

13.2.2 Illumina, Inc. Cancer Biopsy Instruments and Kits Product Offered

13.2.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Illumina, Inc. Main Business Overview

13.2.5 Illumina, Inc. Latest Developments

13.3 Becton, Dickinson and Company

13.3.1 Becton, Dickinson and Company Company Information

13.3.2 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Offered

13.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Becton, Dickinson and Company Main Business Overview

13.3.5 Becton, Dickinson and Company Latest Developments

13.4 Myriad Genetics

13.4.1 Myriad Genetics Company Information

13.4.2 Myriad Genetics Cancer Biopsy Instruments and Kits Product Offered

13.4.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Myriad Genetics Main Business Overview

13.4.5 Myriad Genetics Latest Developments

13.5 Thermo Fisher Scientific, Inc.

13.5.1 Thermo Fisher Scientific, Inc. Company Information

13.5.2 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Offered

13.5.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Thermo Fisher Scientific, Inc. Main Business Overview

13.5.5 Thermo Fisher Scientific, Inc. Latest Developments

13.6 BIOCEPT, INC.

13.6.1 BIOCEPT, INC. Company Information

13.6.2 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Offered

13.6.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 BIOCEPT, INC. Main Business Overview

13.6.5 BIOCEPT, INC. Latest Developments

13.7 ANGLE plc

13.7.1 ANGLE plc Company Information

13.7.2 ANGLE plc Cancer Biopsy Instruments and Kits Product Offered

13.7.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 ANGLE plc Main Business Overview

13.7.5 ANGLE plc Latest Developments

13.8 Hologic, Inc.

13.8.1 Hologic, Inc. Company Information

13.8.2 Hologic, Inc. Cancer Biopsy Instruments and Kits Product Offered

13.8.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hologic, Inc. Main Business Overview

13.8.5 Hologic, Inc. Latest Developments

13.9 Lucence Diagnostics Pte. Ltd.

13.9.1 Lucence Diagnostics Pte. Ltd. Company Information

13.9.2 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Offered

13.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Lucence Diagnostics Pte. Ltd. Main Business Overview

13.9.5 Lucence Diagnostics Pte. Ltd. Latest Developments

13.10 Danaher Corporation

13.10.1 Danaher Corporation Company Information

13.10.2 Danaher Corporation Cancer Biopsy Instruments and Kits Product Offered

13.10.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Danaher Corporation Main Business Overview

13.10.5 Danaher Corporation Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Cancer Biopsy Instruments and Kits Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cancer Biopsy Instruments and Kits Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cancer Biopsy Instruments

Table 4. Major Players of Cancer Biopsy Kits

Table 5. Global Cancer Biopsy Instruments and Kits Sales by Type (2017-2022) & (K Units)

Table 6. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2017-2022)

Table 7. Global Cancer Biopsy Instruments and Kits Revenue by Type (2017-2022) & ($ million)

Table 8. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2017-2022)

Table 9. Global Cancer Biopsy Instruments and Kits Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Cancer Biopsy Instruments and Kits Sales by Application (2017-2022) & (K Units)

Table 11. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2017-2022)

Table 12. Global Cancer Biopsy Instruments and Kits Revenue by Application (2017-2022)

Table 13. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2017-2022)

Table 14. Global Cancer Biopsy Instruments and Kits Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Cancer Biopsy Instruments and Kits Sales by Company (2020-2022) & (K Units)

Table 16. Global Cancer Biopsy Instruments and Kits Sales Market Share by Company (2020-2022)

Table 17. Global Cancer Biopsy Instruments and Kits Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Company (2020-2022)

Table 19. Global Cancer Biopsy Instruments and Kits Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Cancer Biopsy Instruments and Kits Producing Area Distribution and Sales Area

Table 21. Players Cancer Biopsy Instruments and Kits Products Offered

Table 22. Cancer Biopsy Instruments and Kits Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Cancer Biopsy Instruments and Kits Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Cancer Biopsy Instruments and Kits Sales Market Share Geographic Region (2017-2022)

Table 27. Global Cancer Biopsy Instruments and Kits Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Cancer Biopsy Instruments and Kits Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Cancer Biopsy Instruments and Kits Sales Market Share by Country/Region (2017-2022)

Table 31. Global Cancer Biopsy Instruments and Kits Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Cancer Biopsy Instruments and Kits Sales by Country (2017-2022) & (K Units)

Table 34. Americas Cancer Biopsy Instruments and Kits Sales Market Share by Country (2017-2022)

Table 35. Americas Cancer Biopsy Instruments and Kits Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Cancer Biopsy Instruments and Kits Revenue Market Share by Country (2017-2022)

Table 37. Americas Cancer Biopsy Instruments and Kits Sales by Type (2017-2022) & (K Units)

Table 38. Americas Cancer Biopsy Instruments and Kits Sales Market Share by Type (2017-2022)

Table 39. Americas Cancer Biopsy Instruments and Kits Sales by Application (2017-2022) & (K Units)

Table 40. Americas Cancer Biopsy Instruments and Kits Sales Market Share by Application (2017-2022)

Table 41. APAC Cancer Biopsy Instruments and Kits Sales by Region (2017-2022) & (K Units)

Table 42. APAC Cancer Biopsy Instruments and Kits Sales Market Share by Region (2017-2022)

Table 43. APAC Cancer Biopsy Instruments and Kits Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2017-2022)

Table 45. APAC Cancer Biopsy Instruments and Kits Sales by Type (2017-2022) & (K Units)

Table 46. APAC Cancer Biopsy Instruments and Kits Sales Market Share by Type (2017-2022)

Table 47. APAC Cancer Biopsy Instruments and Kits Sales by Application (2017-2022) & (K Units)

Table 48. APAC Cancer Biopsy Instruments and Kits Sales Market Share by Application (2017-2022)

Table 49. Europe Cancer Biopsy Instruments and Kits Sales by Country (2017-2022) & (K Units)

Table 50. Europe Cancer Biopsy Instruments and Kits Sales Market Share by Country (2017-2022)

Table 51. Europe Cancer Biopsy Instruments and Kits Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Cancer Biopsy Instruments and Kits Revenue Market Share by Country (2017-2022)

Table 53. Europe Cancer Biopsy Instruments and Kits Sales by Type (2017-2022) & (K Units)

Table 54. Europe Cancer Biopsy Instruments and Kits Sales Market Share by Type (2017-2022)

Table 55. Europe Cancer Biopsy Instruments and Kits Sales by Application (2017-2022) & (K Units)

Table 56. Europe Cancer Biopsy Instruments and Kits Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Cancer Biopsy Instruments and Kits Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Cancer Biopsy Instruments and Kits Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Cancer Biopsy Instruments and Kits Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Cancer Biopsy Instruments and Kits Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Cancer Biopsy Instruments and Kits Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Cancer Biopsy Instruments and Kits Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Cancer Biopsy Instruments and Kits Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Cancer Biopsy Instruments and Kits Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Cancer Biopsy Instruments and Kits

Table 66. Key Market Challenges & Risks of Cancer Biopsy Instruments and Kits

Table 67. Key Industry Trends of Cancer Biopsy Instruments and Kits

Table 68. Cancer Biopsy Instruments and Kits Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Cancer Biopsy Instruments and Kits Distributors List

Table 71. Cancer Biopsy Instruments and Kits Customer List

Table 72. Global Cancer Biopsy Instruments and Kits Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Cancer Biopsy Instruments and Kits Sales Market Forecast by Region

Table 74. Global Cancer Biopsy Instruments and Kits Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Cancer Biopsy Instruments and Kits Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Cancer Biopsy Instruments and Kits Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Cancer Biopsy Instruments and Kits Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Cancer Biopsy Instruments and Kits Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Cancer Biopsy Instruments and Kits Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Cancer Biopsy Instruments and Kits Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Cancer Biopsy Instruments and Kits Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Cancer Biopsy Instruments and Kits Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Cancer Biopsy Instruments and Kits Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Cancer Biopsy Instruments and Kits Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Cancer Biopsy Instruments and Kits Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Cancer Biopsy Instruments and Kits Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Cancer Biopsy Instruments and Kits Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Cancer Biopsy Instruments and Kits Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Cancer Biopsy Instruments and Kits Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Cancer Biopsy Instruments and Kits Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Cancer Biopsy Instruments and Kits Revenue Market Share Forecast by Application (2023-2028)

Table 92. QIAGEN NV Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 93. QIAGEN NV Cancer Biopsy Instruments and Kits Product Offered

Table 94. QIAGEN NV Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. QIAGEN NV Main Business

Table 96. QIAGEN NV Latest Developments

Table 97. Illumina, Inc. Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 98. Illumina, Inc. Cancer Biopsy Instruments and Kits Product Offered

Table 99. Illumina, Inc. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Illumina, Inc. Main Business

Table 101. Illumina, Inc. Latest Developments

Table 102. Becton, Dickinson and Company Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 103. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Offered

Table 104. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Becton, Dickinson and Company Main Business

Table 106. Becton, Dickinson and Company Latest Developments

Table 107. Myriad Genetics Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 108. Myriad Genetics Cancer Biopsy Instruments and Kits Product Offered

Table 109. Myriad Genetics Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Myriad Genetics Main Business

Table 111. Myriad Genetics Latest Developments

Table 112. Thermo Fisher Scientific, Inc. Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 113. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Offered

Table 114. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Thermo Fisher Scientific, Inc. Main Business

Table 116. Thermo Fisher Scientific, Inc. Latest Developments

Table 117. BIOCEPT, INC. Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 118. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Offered

Table 119. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. BIOCEPT, INC. Main Business

Table 121. BIOCEPT, INC. Latest Developments

Table 122. ANGLE plc Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 123. ANGLE plc Cancer Biopsy Instruments and Kits Product Offered

Table 124. ANGLE plc Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. ANGLE plc Main Business

Table 126. ANGLE plc Latest Developments

Table 127. Hologic, Inc. Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 128. Hologic, Inc. Cancer Biopsy Instruments and Kits Product Offered

Table 129. Hologic, Inc. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Hologic, Inc. Main Business

Table 131. Hologic, Inc. Latest Developments

Table 132. Lucence Diagnostics Pte. Ltd. Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 133. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Offered

Table 134. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Lucence Diagnostics Pte. Ltd. Main Business

Table 136. Lucence Diagnostics Pte. Ltd. Latest Developments

Table 137. Danaher Corporation Basic Information, Cancer Biopsy Instruments and Kits Manufacturing Base, Sales Area and Its Competitors

Table 138. Danaher Corporation Cancer Biopsy Instruments and Kits Product Offered

Table 139. Danaher Corporation Cancer Biopsy Instruments and Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Danaher Corporation Main Business

Table 141. Danaher Corporation Latest Developments

List of Figures

Figure 1. Picture of Cancer Biopsy Instruments and Kits

Figure 2. Cancer Biopsy Instruments and Kits Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cancer Biopsy Instruments and Kits Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Cancer Biopsy Instruments and Kits Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cancer Biopsy Instruments and Kits Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cancer Biopsy Instruments

Figure 10. Product Picture of Cancer Biopsy Kits

Figure 11. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type in 2021

Figure 12. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2017-2022)

Figure 13. Cancer Biopsy Instruments and Kits Consumed in Breast Cancer

Figure 14. Global Cancer Biopsy Instruments and Kits Market: Breast Cancer (2017-2022) & (K Units)

Figure 15. Cancer Biopsy Instruments and Kits Consumed in Colorectal Cancer

Figure 16. Global Cancer Biopsy Instruments and Kits Market: Colorectal Cancer (2017-2022) & (K Units)

Figure 17. Cancer Biopsy Instruments and Kits Consumed in Cervical Cancer

Figure 18. Global Cancer Biopsy Instruments and Kits Market: Cervical Cancer (2017-2022) & (K Units)

Figure 19. Cancer Biopsy Instruments and Kits Consumed in Lung Cancer

Figure 20. Global Cancer Biopsy Instruments and Kits Market: Lung Cancer (2017-2022) & (K Units)

Figure 21. Cancer Biopsy Instruments and Kits Consumed in Others

Figure 22. Global Cancer Biopsy Instruments and Kits Market: Others (2017-2022) & (K Units)

Figure 23. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2017-2022)

Figure 24. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application in 2021

Figure 25. Cancer Biopsy Instruments and Kits Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Company in 2021

Figure 27. Global Cancer Biopsy Instruments and Kits Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Geographic Region in 2021

Figure 29. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2017-2022)

Figure 30. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Country/Region in 2021

Figure 31. Americas Cancer Biopsy Instruments and Kits Sales 2017-2022 (K Units)

Figure 32. Americas Cancer Biopsy Instruments and Kits Revenue 2017-2022 ($ Millions)

Figure 33. APAC Cancer Biopsy Instruments and Kits Sales 2017-2022 (K Units)

Figure 34. APAC Cancer Biopsy Instruments and Kits Revenue 2017-2022 ($ Millions)

Figure 35. Europe Cancer Biopsy Instruments and Kits Sales 2017-2022 (K Units)

Figure 36. Europe Cancer Biopsy Instruments and Kits Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Cancer Biopsy Instruments and Kits Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Cancer Biopsy Instruments and Kits Revenue 2017-2022 ($ Millions)

Figure 39. Americas Cancer Biopsy Instruments and Kits Sales Market Share by Country in 2021

Figure 40. Americas Cancer Biopsy Instruments and Kits Revenue Market Share by Country in 2021

Figure 41. United States Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Cancer Biopsy Instruments and Kits Sales Market Share by Region in 2021

Figure 46. APAC Cancer Biopsy Instruments and Kits Revenue Market Share by Regions in 2021

Figure 47. China Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Cancer Biopsy Instruments and Kits Sales Market Share by Country in 2021

Figure 54. Europe Cancer Biopsy Instruments and Kits Revenue Market Share by Country in 2021

Figure 55. Germany Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Cancer Biopsy Instruments and Kits Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Cancer Biopsy Instruments and Kits Revenue Market Share by Country in 2021

Figure 62. Egypt Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Cancer Biopsy Instruments and Kits Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Cancer Biopsy Instruments and Kits in 2021

Figure 68. Manufacturing Process Analysis of Cancer Biopsy Instruments and Kits

Figure 69. Industry Chain Structure of Cancer Biopsy Instruments and Kits

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450